EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019

Haiyan Wu iD, Shuzhong Liu iD, Hesheng Luo iD, Mingkai Chen iD

Journal of Exploratory Research in Pharmacology · 2021

DOI: 10.14218/jcth.2020.00126 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Exploratory Research in Pharmacology, 2021. Verfasst von Haiyan Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the rapid development of research on coronavirus disease 2019 (COVID-19), more and more attention has been drawn to its damage to extrapulmonary organs. There are increasing lines of evidence showing that liver injury is closely related to the severity of COVID-19, which may have an adverse impact on the progression and prognosis of the patients. What is more, severe acute respiratory syndrome coronavirus-2 infection, cytokine storm, ischemia/hypoxia reperfusion injury, aggravation of the primary liver disease and drug-induced liver injury may all contribute to the hepatic damage in COVID-19 patients; although, the drug-induced liver injury, especially idiosyncratic drug-induced liver injury, requires further causality confirmation by the updated Roussel Uclaf Causality Assessment Method published in 2016. Up to now, there is no specific regimen for COVID-19, and COVID-19-related liver injury is mainly controlled by symptomatic and supportive treatment. Here, we review the clinical features of abnormal liver enzymes in COVID-19 and pathogenesis of COVID-19-related liver injury based on the current evidence, which may provide help for clinicians and researchers in exploring the pathogenesis and developing treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

Abnormal liver enzymesClinical characteristicsCoronavirus disease 2019Idiosyncratic drug-induced liver injuryLiver injuryRoussel Uclaf Causality Assessment Method

Autor:innen und Institutionen

  • Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

ORCID-Profile: Haiyan Wu, Shuzhong Liu, Hesheng Luo, Mingkai Chen

Zitieren

APA

Wu, H., Liu, S., Luo, H., & Chen, M. (2021). Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. Journal of Exploratory Research in Pharmacology. https://doi.org/10.14218/jcth.2020.00126

Vancouver

Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. Journal of Exploratory Research in Pharmacology. 2021. doi:10.14218/jcth.2020.00126

BibTeX
@article{Wu2021,
  author = {Wu, Haiyan and Liu, Shuzhong and Luo, Hesheng and Chen, Mingkai},
  title = {Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019},
  journal = {Journal of Exploratory Research in Pharmacology},
  year = {2021},
  doi = {10.14218/jcth.2020.00126}
}
Kostenlos starten →